FR2319331A1 - Nouveau medicament a base d'un amide heterocyclique - Google Patents

Nouveau medicament a base d'un amide heterocyclique

Info

Publication number
FR2319331A1
FR2319331A1 FR7623195A FR7623195A FR2319331A1 FR 2319331 A1 FR2319331 A1 FR 2319331A1 FR 7623195 A FR7623195 A FR 7623195A FR 7623195 A FR7623195 A FR 7623195A FR 2319331 A1 FR2319331 A1 FR 2319331A1
Authority
FR
France
Prior art keywords
antiarthritic
ribofuranosyl
triazole
contg
carboxamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7623195A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19752533926 external-priority patent/DE2533926A1/de
Priority claimed from DE19752535429 external-priority patent/DE2535429A1/de
Priority claimed from DE19752535428 external-priority patent/DE2535428A1/de
Application filed by Individual filed Critical Individual
Publication of FR2319331A1 publication Critical patent/FR2319331A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/056—Triazole or tetrazole radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7623195A 1975-07-30 1976-07-29 Nouveau medicament a base d'un amide heterocyclique Withdrawn FR2319331A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19752533926 DE2533926A1 (de) 1975-07-30 1975-07-30 Arzneimittel
DE19752535429 DE2535429A1 (de) 1975-08-08 1975-08-08 Arzneimittel
DE19752535428 DE2535428A1 (de) 1975-08-08 1975-08-08 Arzneimittel

Publications (1)

Publication Number Publication Date
FR2319331A1 true FR2319331A1 (fr) 1977-02-25

Family

ID=27186468

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7623195A Withdrawn FR2319331A1 (fr) 1975-07-30 1976-07-29 Nouveau medicament a base d'un amide heterocyclique

Country Status (1)

Country Link
FR (1) FR2319331A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0337701A2 (fr) * 1988-04-11 1989-10-18 May & Baker Limited Utilisation de tétrazole-5-carboxanilides pour le traitement du rejet de greffe, de l'arthrite, des maladies auto-immunes ou des troubles du tissu conjonctif

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0337701A2 (fr) * 1988-04-11 1989-10-18 May & Baker Limited Utilisation de tétrazole-5-carboxanilides pour le traitement du rejet de greffe, de l'arthrite, des maladies auto-immunes ou des troubles du tissu conjonctif
EP0337701A3 (fr) * 1988-04-11 1991-02-06 May & Baker Limited Utilisation de tétrazole-5-carboxanilides pour le traitement du rejet de greffe, de l'arthrite, des maladies auto-immunes ou des troubles du tissu conjonctif

Similar Documents

Publication Publication Date Title
CA2112679A1 (fr) Forme pharmaceutique pour la liberation rapide d'un medicament
DE3070189D1 (en) Medicament, particularly for the treatment of cholera, and pharmaceutical compositions containing it
ES479474A1 (es) Procedimiento para la obtencion de una composicion a base dederivados de la piridina de accion cerebral.
IL76932A (en) Synergistic pharmaceutical analgesic compositions containing dihydrocodeine and ibuprofen
ZA943744B (en) Therapeutic substituted guanidines
ES8601965A1 (es) Un procedimiento para la preparacion de una nueva serie de derivados de (1-piperidinilalquil)pirimidinona
DK599789A (da) 3,5-di-tertiaer-butyl-4-hydroxyphenyl-1,3,4-thiadazoler og -oxadiazoler samt 3,5-di-tertiaer-butyl-4-hydroxyphenyl-1,2,4-thiadazoler, -oxadiazoler og -triazoler som anti-inflammatoriske midler
UA41355C2 (uk) Засіб для лікування нейро-сніду
GR3026369T3 (en) Pharmaceutical preparation containing an uricosuric and an excitatory amino acid antagonist.
SE8002322L (sv) Medel for behandling av inflammatoriska tarmsjukdomar
ZA925146B (en) Pharmaceutical agent for treatment of withdrawal symptoms.
FR2319331A1 (fr) Nouveau medicament a base d'un amide heterocyclique
IL88740A0 (en) Compositions for the inhibition of viruses
BG105008A (en) Hygromycin a derivatives
IL102032A0 (en) 2-amino-5-cyano-1,4-dihydropyridines,their preparation and pharmaceutical compositions containing them
IE893611L (en) Liquid oral formulation
DK0626851T3 (da) Anvendelse af 3,5-diamino-6-(2,3-dichlorphenyl)-1,2,4-triazin til fremstilling af et lægemiddel til behandling af visse typer af smerte og af ødem
GB2204488B (en) Pharmaceutical compositions for the treatment or prophylaxis of skin disorders
BE885291A (fr) Compositions pharmaceutiques pour le traitement des dysfonctionnements cardiaques
NZ184140A (en) Pharmaceutical compositions based on a heterocyclic compound:treatment of skin disorders
HUP0102412A2 (hu) 2"-Dezoxi-higromicin-származékok
ES8403487A1 (es) "procedimiento para la preparacion de n-(2-metoxietil)-noroximorfona".
ES2065855A1 (es) Procedimiento para la preparacion de nuevos derivados desoxiazafosfolipidicos con accion inhibidora de la fosfolipasa a2, nuevos derivados desoxiazafosfolipidicos obtenidos y utilizacion de los mismos.
FR2351655A1 (fr) Nouveau derive de la thiazolo (3,4-b) isoquinoleine, sa preparation et les compositions qui le contiennent
FR2284331A1 (fr) Produits pharmaceutiques contenant un compose organo-silicie en tant qu'agent actif

Legal Events

Date Code Title Description
ST Notification of lapse